Key TakeawaysIBM (IBM) and Advanced Micro Devices (AMD) led pre-market gains, with IBM rising 4.3% on a strategic partnership with Anthropic and AMD surging 4% after a Jefferies upgrade to a $300 price target following a significant OpenAI deal.Johnson & Johnson (JNJ) announced positive Phase 2b study results for its investigational oral drug icotrokinra in ulcerative colitis, demonstrating a 63.5% clinical response rate at the highest dose, and reaffirmed the known safety record of its drug Tremfya.BofA Gl ...